Literature DB >> 8267684

Penile vascular evaluation of men with Peyronie's disease.

J A Lopez1, J P Jarow.   

Abstract

A penile vascular evaluation was performed upon 95 consecutive men with Peyronie's disease (19 potent and 76 impotent) and 100 consecutive impotent men without Peyronie's disease to gain further understanding of the pathophysiology of erectile dysfunction in patients with Peyronie's disease. Only 1 of the 19 potent patients with Peyronie's disease had abnormal arterial blood flow by duplex ultrasonography and none had evidence of veno-occlusive dysfunction by either duplex ultrasonography or dynamic infusion cavernosometry/cavernosography. In contrast, 36% of the impotent men with Peyronie's disease had abnormal arterial blood flow and 59% had evidence of veno-occlusive dysfunction. There was no significant difference in historical risk factors for impotence between the impotent patients with Peyronie's disease and the control population of impotent patients. However, the presence of veno-occlusive dysfunction in the control population (16%) was significantly less than that of the impotent Peyronie's disease patients (p < 0.001). Although patients with Peyronie's disease may suffer impotence due to arterial occlusive disease, our results indicate that the principal cause of impotence in this patient population is veno-occlusive dysfunction.

Entities:  

Mesh:

Year:  1993        PMID: 8267684     DOI: 10.1016/s0022-5347(17)35997-9

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  14 in total

1.  Plaque incision and venous patch grafting for Peyronie's disease.

Authors:  Ahmet Metin; Onder Kayigil; S Iftekhar Ahmed
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

2.  Peyronie's Disease: A Review.

Authors:  Mark Jalkut; Nestor Gonzalez-Cadavid; Jacob Rajfer
Journal:  Rev Urol       Date:  2003

3.  Patient-partner satisfaction with intracavernous medication supported with oral agents in selected cases of Peyronie's disease. A ten-month follow-up study.

Authors:  M Culha; N Mutlu; O Acar; B Alici
Journal:  Int Urol Nephrol       Date:  1999       Impact factor: 2.370

4.  Effects of sildenafil treatment on patients with Peyronie's disease and erectile dysfunction.

Authors:  U Ozturk; S Yesil; H N G Goktug; A Gucuk; C Tuygun; N C Sener; I Nalbant; M A Imamoglu
Journal:  Ir J Med Sci       Date:  2013-11-05       Impact factor: 1.568

Review 5.  Investigation of erectile dysfunction.

Authors:  D V Patel; J Halls; U Patel
Journal:  Br J Radiol       Date:  2012-11       Impact factor: 3.039

Review 6.  Surgery for Peyronie's disease.

Authors:  Laurence A Levine; Stephen M Larsen
Journal:  Asian J Androl       Date:  2012-11-26       Impact factor: 3.285

7.  Antioxidant Mechanism of Xiaojin Pill () for Treatment of Peyronie's Disease in Rats Based on Matrix Metalloproteinases.

Authors:  Qiang Geng; Fu Wang; Qiang Han; Shao-Feng Chen; Bin Ouyang; Zhong Li; Yu Zhao; Qing-He Gao; Guo-Jin Yu; Jun Guo
Journal:  Chin J Integr Med       Date:  2019-10-24       Impact factor: 1.978

Review 8.  Stem-cell therapy for erectile dysfunction: a review of clinical outcomes.

Authors:  Mingyue He; Ernst R von Schwarz
Journal:  Int J Impot Res       Date:  2020-04-29       Impact factor: 2.896

9.  US Imaging in Peyronie's Disease.

Authors:  Kiriaki Kalokairinou; Charalampos Konstantinidis; Marilena Domazou; Theodoros Kalogeropoulos; Prodromos Kosmidis; Aristomenis Gekas
Journal:  J Clin Imaging Sci       Date:  2012-10-31

Review 10.  Conservative management options for Peyronie's disease.

Authors:  Gregory S Jack; Nestor Gonzalez-Cadavid; Jacob Rajfer
Journal:  Curr Urol Rep       Date:  2005-11       Impact factor: 2.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.